Search Results - "Kohn, A E"

A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders by Posey, D J, Guenin, K D, Kohn, A E, Swiezy, N B, McDougle, C J

“…The aim of this study was to conduct a naturalistic, open-label examination of the efficacy and tolerability of mirtazapine (a medication with both…”
Get more information

Abrogation of the S Phase DNA Damage Checkpoint Results in S Phase Progression or Premature Mitosis Depending on the Concentration of 7-Hydroxystaurosporine and the Kinetics of Cdc25C Activation by Kohn, Ethan A., Ruth, Nicola D., Brown, Mary Kay, Livingstone, Mark, Eastman, Alan

“…DNA damage causes cell cycle arrest in G1, S, or G2 to prevent replication on damaged DNA or to prevent aberrant mitosis. The G1 arrest requires the p53 tumor…”
Get full text

When the cannons roar, comics panels fall silent: on silent representations of traumatic events in Israeli comics and graphic novels by Adler, Silvia, Kohn, Ayelet

“…The present study examines silent panels in five Israeli graphic novels and comics that deal - directly or indirectly - with traumatic events, whether…”
Get full text

Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G sub(2) cell cycle checkpoints by Levesque, A A, Kohn, E A, Bresnick, E, Eastman, A

“…The topoisomerase I inhibitor SN38 arrests cell cycle progression primarily in S or G sub(2) phases of the cell cycle in a p53-independent manner. The Chkl…”
Get full text

Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G cell cycle checkpoints

Get full text

The Protein Kinase C Inhibitor Goe6976 Is a Potent Inhibitor of DNA Damage-induced S and G sub(2) Cell Cycle Checkpoints by Kohn, E A, Yoo, C J, Eastman, A

“…In response to DNA damage, cells arrest progression through the cell cycle at either G sub(1), S, or G sub(2). We have reported that UCN-01…”
Get full text

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials by Arnold, L Eugene, Vitiello, Benedetto, McDougle, Christopher, Scahill, Larry, Shah, Bhavik, Gonzalez, Nilda M, Chuang, Shirley, Davies, Mark, Hollway, Jill, Aman, Michael G, Cronin, Pegeen, Koenig, Kathleen, Kohn, Arlene E, McMahon, Donald J, Tierney, Elaine

“…A consumer-oriented efficacy assessment in clinical trials should measure changes in chief complaint and consumer request (symptoms of most concern to…”
Get more information

A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01 by Eastman, Alan, Kohn, Ethan A, Brown, Mary Kay, Rathman, Joerg, Livingstone, Mark, Blank, David H, Gribble, Gordon W

“…DNA damaging agents such as cisplatin arrest cell cycle progression at either G1, S, or G2 phase, although the G1 arrest is only seen in cells expressing the…”
Get full text